Brian Nappi | SVP, Strategy
Saol Therapeutics

Day 1 - World Orphan Drug Congress USA 2026 @ 15:30

Rare Launch Readiness: Building the Foundation for Commercial Success

As rare disease therapies move from development to commercialization, companies face a uniquely complex launch landscape—small, geographically dispersed patient populations, nuanced clinical value communication, limited real-world data, and the need for deep trust with patient communities. This panel brings together commercial leaders, market access strategists, and patient-focused experts to explore what it truly takes to build a launch-ready organization in the rare disease space.